Posted December 31, 2009

Available Funding: A maximum of $5,000 for the four week training rotation will be provided for each location, New York, Los Angeles, and Milan. Funding is available for up to 2 residents. Any expenses exceeding this amount are the responsibilities of the resident awardee.

About the Grant: This grant opportunity is for pathology residents and fellows in training who seek to gain advanced diagnostic experience in hematologic and solid tumor malignancies. Residents will have the opportunity to work in one of two state of the art laboratories located in Manhattan, New York or Los Angeles, California. There is only one laboratory in Milan, Italy and residents will work under the overall direction of Michael Dugan, MD, FCAP.

Location supervisors for New York will be Bruce Horten, MD, FCAP, and Henry Dong, MD, FCAP. Supervisors for Los Angeles will be Moacyr DaSilva, MD, FCAP, and Jess Savala, MD. The Milan, Italy supervisor will be Juan Rosai, MD, FCAP.

Expected Accomplishments for Residents:

1. Obtain hands-on experience with high volume, challenging hematologic and solid tumor diagnostic consultations. The training in Milan will be focused on diagnostic consultation, primarily solid tumor, with accompanying IHC under the direction of Dr. Juan Rosai.



2. Receive detailed instruction and hands-on experience (in NY or LA only) with
1. Flow cytometry
2. Molecular technologies
3. Cytogenetics
4. Fluorescence in situ hybridization (FISH)
5. Immunohisochemistry (IHC)



3. Participate in review of diagnostic consultations regarding rare or unusual tumors.



4. In Milan, the awardee will receive detailed exposure to rare cases forwarded to Dr. Rosai from around the world. This would be about 50% thyroid/mediastinal tumors and about 50% other cases. The case mix would be about 50% from U.S. and 50% from other countries. The fellow would receive experience in Immunohistochemistry (IHC) interpretation related to this cases and help prepare the reports generated by Dr. Rosai.

Additional information on curriculum.

Eligibility Requirements:

• Applicant must be a Junior Member of CAP or have an application in process



• Applicant must have at least one year of AP training including at least six months of applicable surgical pathology training, and at least 2 months of hematopathology related training.



• Additional experience in hematopathology or genetics preferred.

Selection Criteria:
Application will be judged on the following:

• Merit of application and narrative



• Education value to the applicant



• Applicant background and current knowledge of pathology practice



• Program director’s recommendation

Reporting Requirements

• After completion of rotation, the grant recipient(s) must submit a report and evaluation of the experience to CAP Foundation which will be shared with Genzyme Genetics.



• The CAP Foundation may communicate the results of the completed project to CAP resource committees and Genzyme Genetics Medical Directors who are best positioned to use them. Copies of any communications sent will be mailed to the award recipient.



• Recipients are to submit a photo(s) and share their experience in writing with others.



• The grant recipient(s) may submit an abstract of his/her research experience or project to the CAP and/or other pathology related annual meetings.